LHLABORATORY CORP OF AMERICA ...

NYSE labcorp.com


$ 218.38 $ 1.89 (0.87 %)    

Thursday, 28-Mar-2024 15:59:57 EDT
QQQ $ 443.93 $ -0.82 (-0.18 %)
DIA $ 397.72 $ 0.20 (0.05 %)
SPY $ 523.07 $ -0.10 (-0.02 %)
TLT $ 94.55 $ -0.08 (-0.08 %)
GLD $ 205.72 $ 2.62 (1.29 %)
$ 218.46
$ 216.24
$ 0.00 x 0
$ 0.00 x 0
$ 215.96 - $ 218.62
$ 177.96 - $ 233.32
607,583
na
19.33B
$ 1.10
$ 46.25
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-26-2024 12-31-2023 10-K
2 10-30-2023 09-30-2023 10-Q
3 08-04-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-01-2022 09-30-2022 10-Q
7 08-01-2022 06-30-2022 10-Q
8 04-29-2022 03-31-2022 10-Q
9 02-25-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-25-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-28-2020 12-31-2019 10-K
18 10-31-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-03-2019 03-31-2019 10-Q
21 02-28-2019 12-31-2018 10-K
22 10-30-2018 09-30-2018 10-Q
23 07-27-2018 06-30-2018 10-Q
24 05-01-2018 03-31-2018 10-Q
25 02-27-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 10-28-2016 09-30-2016 10-Q
31 07-29-2016 06-30-2016 10-Q
32 05-06-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 10-30-2015 09-30-2015 10-Q
35 07-30-2015 06-30-2015 10-Q
36 05-04-2015 03-31-2015 10-Q
37 02-26-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 07-29-2014 06-30-2014 10-Q
40 04-29-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 labcorp-expands-diagnostic-reach-with-strategic-deal-for-select-assets-of-bioreference-health

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate abo...

Core News & Articles

Transaction to enhance Labcorp's laboratory services network and expand access to the company's high-quality clinical l...

 argus-research-upgrades-laboratory-corp-to-buy

Argus Research analyst David Toung upgrades Laboratory Corp (NYSE:LH) from Hold to Buy.

 reported-saturday-labcorp-presented-new-research-demonstrating-clinical-impact-of-precision-diagnostics-in-guiding-biomarker-targeted-therapies-for-patients-with-epithelial-ovarian-cancer

Outcomes point to value of biomarker testing in addressing testing gaps in clinical practice

 labcorp-introduces-its-weight-loss-management-portfolio

The new offering features educational resources and convenient testing solutions, equipping individuals and their physicians wi...

 leerink-partners-initiates-coverage-on-laboratory-corp-with-outperform-rating-announces-price-target-of-260

Leerink Partners analyst Michael Cherny initiates coverage on Laboratory Corp (NYSE:LH) with a Outperform rating and announc...

 laboratory-corp-q4-adjusted-eps-330-beats-328-estimate-sales-303b-beat-301b-estimate

Laboratory Corp (NYSE:LH) reported quarterly earnings of $3.30 per share which beat the analyst consensus estimate of $3.28 by ...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 evercore-isi-group-initiates-coverage-on-laboratory-corp-with-in-line-rating-announces-price-target-of-240

Evercore ISI Group analyst Elizabeth Anderson initiates coverage on Laboratory Corp (NYSE:LH) with a In-Line rating and anno...

 evolving-landscape-for-alzheimers-blood-tests-gains-momentum-amid-inaccuracy-concerns

A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the ...

 labcorp-collaborates-with-hawthorne-for-direct-clinical-trials-for-patients-and-investigators

Collaboration Aims to Improve Patient Experience, Accessibility and Efficiency in Decentralized Clinical Trials

 barclays-initiates-coverage-on-laboratory-corp-with-equal-weight-rating-announces-price-target-of-222

Barclays analyst Stephanie Davis initiates coverage on Laboratory Corp (NYSE:LH) with a Equal-Weight rating and announces Pr...

 slb-marvell-technology-and-2-other-stocks-insiders-are-selling

The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades.

 jp-morgan-maintains-overweight-on-laboratory-corp-raises-price-target-to-261

JP Morgan analyst John Stansel maintains Laboratory Corp (NYSE:LH) with a Overweight and raises the price target from $259 t...

 geneoscopy-signs-multi-year-agreement-with-labcorp-to-distribute-noninvasive-multi-target-stool-rna-colorectal-cancer-screening-test

Collaboration expected to increase provider and patient access to potentially life-saving colorectal cancer screening that enab...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION